Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
This piece explains typical timelines and triggers for index rule updates, helping you anticipate changes and align investment decisions with the latest rules.
11,884 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Tech-led selling pushed the Nasdaq Composite lower as investors weigh higher yields and fresh data. The broader marke...
IBM leads the Dow movers while Sherwin-Williams slides, as analysts clash over Salesforce and the software rotation t...
As volatility persists in 2026, a small-cap dividend ETF is drawing renewed interest from retirees seeking steady inc...
USO has jumped 64% year to date, yet its long-term track record flags a stubborn drag from futures contango. Analysts...
Rising tensions over the Strait of Hormuz have sparked volatile moves in oil and equity markets as U.S. intelligence ...
Dividend income can weather downturns better than stocks, but it isn’t immune. This report explains why payouts hold ...
Pop culture’s most famous aliens can teach real-world money skills. Explore 10 iconic aliens don’t star and the pract...
Stocks edge higher pre-market as oil nears $100 a barrel, lifting energy names while weighing inflation and growth pr...
A large Iranian-linked vessel crossed the Strait of Hormuz, with several others following in a week of heightened sec...
The March NAHB/Wells Fargo HMI shows homebuilder confidence nudges remains at 38, signaling a tepid market as incenti...
The crypto world is buzzing as BTC approaches 92k amid ETF filings and regulatory signals. This guide breaks down wha...